Centralized vs Decentralized Molecular Infectious Disease Testing

Clin Chem. 2021 Apr 29;67(5):713-719. doi: 10.1093/clinchem/hvaa318.

Sheldon Campbell^{1

2}, Neil Anderson^{3

4}, Esther Babady⁵, Thomas J S Durant^{6

7}, Ann Fisher^{8

9}, Norman Moore¹⁰

¹ Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.
² Pathology and Laboratory Medicine, VA Connecticut Health Care, West Haven, CT, USA.
³ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
⁴ Clinical Microbiology and Molecular Diagnostics Laboratories, Barnes Jewish Hospital, St. Louis, MO, USA.
⁵ Clinical Microbiology Service; Department of Laboratory Medicine and Medicine; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Chemical Pathology Laboratory and Laboratory ITS, Yale-New Haven Hospital, New Haven, CT, USA.
⁷ Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.
⁸ Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.
⁹ Antimicrobial Stewardship and Epidemiology, VA Connecticut Health Care, West Haven, CT, USA.
¹⁰ Abbott Diagnostics, USA.

No abstract available

Publication types